Picture of Quantrx Biomedical logo

QTXB Quantrx Biomedical Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Quantrx Biomedical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line0.869-0.737-0.622-0.253-0.26
Depreciation
Non-Cash Items-1.280.2690.222-0.0250
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.2490.210.2080.2020.211
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities-0.151-0.258-0.192-0.075-0.049
Other Investing Cash Flow Items0.4970.2010
Sale of Intangible Assets
Cash from Investing Activities0.4970.2010
Financing Cash Flow Items00
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.113-0.081000
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.459-0.138-0.192-0.075-0.049